Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- C4 Therapeutics, Inc.
Updated Jul 16, 2026
GROGAN DONNA ROY has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 3.3K | $4.34 | $14K |
| 2026-04-03 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 5.4K | $2.70 | $14K |
| 2025-10-01 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 6.7K | $2.15 | $14K |
| 2025-07-01 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 9.6K | $1.51 | $15K |
| 2024-10-02 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 2.5K | $5.56 | $14K |
GROGAN DONNA ROY is a corporate insider — currently tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GROGAN DONNA ROY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.